Marc Wilson
CIK 1702265 · CFO · last filed 2024-09-30
Marc Wilson is a CFO who has filed 17 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for CRNX, was dated Sep 30, 2024. Across all open-market trades the lifetime net is −$6.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.69M
2
17
-$6.64M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRNX | CFO | 136,092 | $34.47 | $4.69M | -$6.64M | 15 | 2024-09-30 |
| Cidara Therapeutics, Inc. (CDTX) Delisted | Chief Accounting Officer | 10,356 | $221.38 | $2.29M | $0 | 2 | 2017-09-19 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-30 | CRNX | Mixed | — | -$895.5K | EDGAR |
| 2024-07-26 | CRNX | Mixed | — | -$849.9K | EDGAR |
| 2024-07-17 | CRNX | Mixed | — | -$874.5K | EDGAR |
| 2024-07-02 | CRNX | Mixed | — | -$1.10M | EDGAR |
| 2024-03-20 | CRNX | Mixed | −10,925 | -$449.8K | EDGAR |
| 2024-03-06 | CRNX | Grant (A) | +25,500 | $0 | EDGAR |
| 2024-01-04 | CRNX | Mixed | — | -$261.9K | EDGAR |
| 2023-11-03 | CRNX | Mixed | — | -$194.7K | EDGAR |
| 2023-06-21 | CRNX | Mixed | −10,922 | -$431.8K | EDGAR |
| 2023-03-17 | CRNX | Tax (F) | −1,666 | -$28.5K | EDGAR |